Cat Lutz (IMAGE)
Caption
Cathleen (Cat) Lutz, vice president of the Rare Disease Translational Center at JAX, emphasized the broader implications of the breakthrough, calling it a major step toward personalized therapies for rare genetic disorders.
Credit
The Jackson Laboratory
Usage Restrictions
none
License
Licensed content